Genomic Health, Inc. To Present At JMP Securities Research Conference And Lehman Brothers Global Healthcare Conference

REDWOOD CITY, Calif., March 2 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced that Kim Popovits, the Company’s President and Chief Operating Officer, will present at the JMP Securities Research Conference in San Francisco, CA on Tuesday, March 7, 2006 at 3:15 p.m. Pacific Time.

The Company also announced that Randy Scott, Ph.D., the Company’s Chairman and Chief Executive Officer, will present at the Lehman Brothers Ninth Annual Global Healthcare Conference in Miami, FL on Wednesday, March 8, 2005 at 10:45 a.m. Eastern Time.

To access the live and subsequently archived webcasts of both presentations, visit the Investor Relations section of Genomic Health’s website at http://investor.genomichealth.com . Please connect to the web site at least 15 minutes prior to the beginning of the presentation to allow for any necessary software downloads. An archived replay will be available for three months beginning 24 hours after the live presentation.

About Genomic Health

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(TM), which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit www.genomichealth.com.

Genomic Health, Inc.

CONTACT: Brad Cole of Genomic Health, Inc., +1-650-569-2281, orinvestors@genomichealth.com; or Emily Faucette of WeissComm Partners,+1-415-946-1066, or media@genomichealth.com, for Genomic Health, Inc.

MORE ON THIS TOPIC